Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05797831
Title	Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Recruitment	Recruiting
Gender	female
Phase	Phase II
Variant Requirements	Yes
Sponsors	Kartos Therapeutics, Inc.
Indications	endometrial cancer
Therapies	KRT-232
Age Groups:	adult \| senior
Covered Countries	USA \| SWE \| SVN \| ROU \| POL \| NOR \| LTU \| ITA \| ISR \| HUN \| FIN \| EST \| ESP \| DNK \| CAN \| AUT